Pulling SEC filings + quote and writing the call…

OP Bancorp
Next earnings Jul 21, 2026 · consensus $0.46 EPS, $25.7M rev
Last earnings -0.4% on 2026-04-23
Cheap, well-capitalized Korean-American community bank: ~1x book, 8.8x earnings, 11% ROE, double-digit profit growth — worth owning.
Diluted EPS $1.72 · FY2025
Quality fundamentals and an attractive price line up (~180% below fair value) — the rarer case where both the business and the entry look good.
Ignore the headline P/S of 70x and the 800% "net margin" — those are artifacts of bank accounting. The $3.20M "revenue" XBRL tag captures only fee/contract income; OPBK's real engine is net interest income from Open Bank plus SBA loan-sale gains, and the number that matters is net income of $25.6M (+21.7% YoY) on diluted EPS of $1.72 (+23.7%). The stock trades at 8.8x that EPS and, with $228M of equity against 14.9M shares, at roughly book value ($15.30/share vs. a $15.14 price, ~1.0x P/B). A bank compounding earnings at a double-digit clip, earning an 11.2% ROE, and paying out ~$0.48/share (a ~3.2% yield) for one times book is priced for pessimism, not the modest, profitable growth it is actually delivering.
The balance sheet supports the call. Total assets grew 12% to $2.65B, equity rose 11.2% to $228M, and cash climbed 24% to $167M, so the franchise is funding growth internally while retained earnings build (+13.7% to $153M). The MD&A frames a constructive rate backdrop: the Fed paused at 3.50–3.75% after three cuts in late 2025, which relieves deposit-repricing pressure on funding costs — the key swing factor for a spread lender that relies on locally generated deposits. Management also cleared two regulatory overhangs cleanly: it fell below the $5B threshold and is exempt from the Part 363 ICFR audit, and it assessed the March 2026 SBA eligibility rule change (elimination of the 5% noncitizen-ownership allowance) as not materially adverse to its SBA portfolio despite SBA lending being 'a substantial portion' of activity.
Is OPBK a buy? The one-page verdict, explained →
BUY verdict with defined risk: the short call finances part of the long one; max loss is the net debit.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $1.56M | $1.68M | $2.12M | $3.26M | $3.20M |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $28.8M | $33.3M | $23.9M | $21.1M | $25.6M |
| Diluted EPS | $1.88 | $2.14 | $1.55 | $1.39 | $1.72 |
| Net margin | 1846.4% | 1988.7% | 1126.6% | 646.1% | 800.1% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Annual meeting vote results filed; routine director/auditor ratification, no surprises
Q1 2026 10-Q; assets $2.65B, growth intact but filed after late-notice
Late-filing notice for Q1 2026 10-Q — mild disclosure/reporting timing concern
Q1 2026 earnings release; continued profit momentum off record FY2025
Proxy for 2026 annual meeting; routine board/comp/auditor items
FY2025 10-K: net income $25.6M (+22%), EPS $1.72, assets +12% to $2.65B
FY2025 results: net income +22%, diluted EPS $1.72 (+24%)
New debt obligation/material agreement (item 2.03) — added leverage to fund growth
Q3 2025 10-Q; earnings recovery vs 2024, balance sheet expanding
Sources: SEC EDGAR (CIK 0001722010, latest 10-Q filed 2026-05-15) · EODHD · Proprietary analysis · as of 7/3/2026, 11:09:05 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 3, 2026, 7:09 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 3 sales
| 2026-07-01 | OH Sang Kyo Chief Executive Officer | Exercise | 5.87K | |
| 2026-06-24 | OH Sang Kyo Chief Executive Officer | Exercise | 9.00K | |
| 2026-06-12 | Oh Christine Yoon Chief Operating Officer | Sell | 1.55K @ $14.20 | $22.0K |
| 2026-06-11 | Oh Christine Yoon Chief Operating Officer | Sell | 8.25K @ $14.08 | $116K |
| 2026-06-10 | Oh Christine Yoon Chief Operating Officer | Sell | 12.0K @ $14.29 | $172K |
| 2026-06-08 | Park Jae H. Chief Risk Officer | Exercise | 3.85K | |
| 2026-06-08 | Park Jae H. Chief Risk Officer | Tax | 1.24K @ $14.15 | $17.6K |
| 2026-05-28 | YOON KI WON Director | Exercise | 2.41K | |
| 2026-05-28 | Sohn Myung Shin Director | Exercise | 2.41K | |
| 2026-05-28 | Kim Hyung J Director | Exercise | 2.41K | |
| 2026-05-28 | Kwon Sunny Director | Exercise | 2.41K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median